Real-World Study Analysing Progression and Survival of Patients with Idiopathic Pulmonary Fibrosis with Preserved Lung Function on Antifibrotic Treatment

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible lung disease. Licensed treatment options for IPF are pirfenidone and nintedanib. The aim of this study was to assess the impact of antifibrotic therapy in patients with IPF with preserved lung function based...

Descripción completa

Detalles Bibliográficos
Autores principales: Noor, Saba, Nawaz, Saira, Chaudhuri, Nazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854391/
https://www.ncbi.nlm.nih.gov/pubmed/33098554
http://dx.doi.org/10.1007/s12325-020-01523-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854391/
https://www.ncbi.nlm.nih.gov/pubmed/33098554
http://dx.doi.org/10.1007/s12325-020-01523-7

Ejemplares similares